Adults Olanzapine is indicated for the treatment of schizophrenia. Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response. Olanzapine is indicated for the treatment of moderate to severe manic episode. In patients whose manic episode has responded to olanzapine treatment, olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder (see section 5.1).
The FDA has concluded a review of a study undertaken to determine the cause of elevated levels of the injectable...
The FDA has approved the first generic versions of Zyprexa (olanzapine tablets) and Zyprexa Zydus (olanzapine orally disintegrating tablets) to...
Following the deaths of two patients with Schizophrenia who had received intramuscular injections with Eli Lilly's Zyprexa Relprevv (olanzapine pamoate),...